To further identify a potential causative link between FoxO3a overexpression and AAA development, we used an AAV carrying a FoxO3a overexpression plasmid to perform gain-of-function studies in Ang II-perfused C57BL/6J mice treated with AAV-FoxO3a. The gene discussed is FOXO3; the disease is triple-A syndrome.